Acadia Pharmaceuticals ACAD Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's intangible amortization?
- Acadia Pharmaceuticals (ACAD) reported intangible amortization of $2.72M in Q1 2026.
- How has Acadia Pharmaceuticals's intangible amortization changed year-over-year?
- Acadia Pharmaceuticals's intangible amortization decreased by 0.0% year-over-year, from $2.72M to $2.72M.
- What is the long-term trend for Acadia Pharmaceuticals's intangible amortization?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's intangible amortization has grown at a 74.7% compound annual growth rate (CAGR), from $1.17M to $10.89M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.